| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |